z-logo
open-access-imgOpen Access
Coronavirus disease 2019 (COVID‐19) as a potential trigger for benign recurrent intrahepatic cholestasis
Author(s) -
Çalhan Turan,
Yivli Elif
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5557
Subject(s) - medicine , cholestasis , covid-19 , disease , coronavirus , jaundice , liver disease , pandemic , infectious disease (medical specialty)
Abstract Benign recurrent intrahepatic cholestasis (BRIC) is a rare disease characterized by recurrent severe itching and jaundice. Coronavirus disease 2019 (COVID‐19) is a multisystemic acute viral disease and the liver is frequently affected. Here, we wanted to present a BRIC case triggered by COVID‐19 infection, discussing it together with current information.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here